Ira R. Horowitz, MD, SM, FACOG, FACS
John D. Thompson Professor and Chairman

Ira Horowitz

Gynecologic Oncology

Chief Medical Officer, Emory University Hospital

Associate Director, The Emory Clinic

Assistant Dean, Clinical Affairs, Emory University School of Medicine

Associate Dean of Clinical Services, Emory University Hospital


button

Education & Training   


Medical Education: Baylor College of Medicine, MD, 1980 

Residency: Baylor College of Medicine, Department of Obstetrics and Gynecology, 1984

Fellowship: Gynecologic Oncology, The Johns Hopkins Medical Institutions, 1987

Graduate Education: Harvard School of Public Health, SM, 2004

Certifications: 
•  American Board of Obstetrics and Gynecology, Obstetrics and Gynecology, 1988
•  American Board of Obstetrics and Gynecology, Gynecologic Oncology, 1989


Society & Professional Memberships  


•  The American Medical Association
•  Mid-Atlantic Gynecologic Oncology Society
•  Southern Medical Association
•  Fellow, American College of Obstetricians and Gynecologists
•  American Society of Clinical Oncology
•  Society of Gynecologic Oncologists
•  Fellow, American College of Surgeons
•  Georgia Obstetrical and Gynecological Society
•  Johns Hopkins OB/GYN Alumni Howard A. Kelly Society
•  Atlanta Obstetrical and Gynecological Society
•  Georgia Chapter of the American College of Surgeons
•  Society of Gynecologic Surgeons
•  International Gynecologic Society 
•  Society of Surgical Oncology
•  World Endometriosis Society
•  International Gynecologic Cancer Society

 
Awards and Honors


•  Top Doctors, Atlanta Magazine, 2013, 2012, 2011, 2010, 2009
•  Top Doctors, US News and World Report
•  Excellence in Teaching Award, Association of Professors in Gynecology and Obstetrics, 1997 

I See Patients At


Emory Clinic, Emory University Campus
Bldg A, 4th Floor
1365 Clifton Rd.
Atlanta, GA 30322
Phone: 404−778−3401
Directions and Map 


Academic


Emory University School of Medicine 
Department of Gynecology and Obstetrics 
1639 Pierce Drive, Room 4208 WMB
Atlanta, GA 30322 

Clinical


•  Endometrial cancer
•  Ovarian cancer
•  Vulvar cancer
•  Uterine cancer
•  Fallopian tube cancer
•  Vaginal cancer
•  Gestational trophoblastic cancer
•  Minimally invasive surgery
•  Laparoscopic surgery 


Research


•  Epidemiology and treatment of cervical cancer
•  Etiology and treatment of ovarian cancer  
•  Screening and treatment of gynecologic cancer
•  HPV and its role in urogenital tumors  

Selected Research Articles


  • Is the incidence of Heparin-Induced Thrombocytopenia Affected by the Increased Use of Heparin for the Prevention of Deep Venous Thrombosis? Zhou A, Winkler A, Emamifar A, Gartland B, Duncan A, Antun A, Arellano M, Tindol GA, Levy JH, Bornstein WA, Horowitz IR, Khoury HJ. CHEST 2012:142(5):1175-1178. PMID: 22539642.
  • Age-group differences in human papillomavirus types and cofactors for cervical intraepithelial neoplasia 3 among women referred to colposcopy. Gargano JW, Nisenbaum R, Lee DR, Ruffin MT 4th, Steinau M, Horowitz IR, Flowers LC, Tadros TS, Birdsong G, Unger ER. Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):111-21. Epub 2011 Oct 25.
  • Controversies in the management of advanced ovarian cancer. Khanna N, Horowitz IROncology (Williston Park). 2011 Sep;25(10):934, 937.
  • Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status. Skates SJ, Mai P, Horick NK, Piedmonte M, Drescher CW,
    Isaacs C, Armstrong DK, Buys SS, Rodriguez GC, Horowitz IR, Berchuck A, Daly MB, Domchek S, Cohn DE, Van Le L, Schorge JO, Newland W, Davidson SA, Barnes M, Brewster W, Azodi M, Nerenstone S, Kauff ND, Fabian CJ, Sluss PM, Nayfield SG, Kasten CH, Finkelstein DM, Greene MH, Lu K. Cancer Prev Res (Phila). 2011 Sep;4(9):1401-8.
  • Multiple anticancer activities of EF24, a novel curcumin analog, on human ovarian carcinoma cells. Tan X, Sidell N, Mancini A, Huang RP, Shenming Wang,Horowitz IR, Liotta DC, Taylor RN, Wieser F. Reprod Sci. 2010 Oct;17(10):931-40. Epub 2010 Aug 6.
  • Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: a Gynecologic Oncology Group study. Fleming GF, Sill MW, Darcy KM, McMeekin DS, Thigpen JT, Adler LM, Berek JS, Chapman JA, DiSilvestro PA, Horowitz IR, Fiorica JV. Gynecol Oncol. 2010 Jan;116(1):15-20. Epub 2009 Oct 18.
  • Female Genital System. Horowitz Ira R. Eds Wood WC; Staley CA; Skadalakis JE. Anatomic Basis of Tumor Surgery, Second Edition, 637-680 DOI: 10.1007/978-3-540-74177-0_14. 2010.
  • Lymphadenectomy for patients with cervical cancer: is it of value? Rossi PJ, Horowitz IR, Johnstone PA, Jani AB. J Surg Oncol. 2009 Oct 1;100(5):404-6.
  • Proteomics-based approach to elucidate the mechanism of antitumor effect of curcumin in cervical cancer. Madden K, Flowers L, Salani R, Horowitz I, Logan S, Kowalski K, Xie J, Mohammed SI. Prostaglandins Leukot Essent Fatty Acids. 2009 Jan;80(1):9-18. Epub 2008 Dec 5.
  • Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: a SEER registry analysis. Rossi PJ, Jani AB, Horowitz IR, Johnstone PA. Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):134-8. Epub 2007 Sep 12.